SAN FRANCISCO, Oct. 12 /PRNewswire/ -- WeissComm Partners, a rapidly growing boutique agency solely focused on the healthcare industry, today announced the addition of four new clients to its growing client roster, including BioMarin Pharmaceutical, Inc., CV Therapeutics, Inc., OTN (Oncology Therapeutics Network) and Protein Design Labs Inc. (PDL).
"WeissComm has experienced tremendous growth this year and the addition of these four new clients reflects the creative and strategically sound communications programs we provide that can make a real bottom-line difference to their business," said Diane Weiser, chief operating officer of WeissComm. "To support our growing business, we have continued to hire experienced professionals in our expanding San Francisco and New York offices who will provide the excellent level of service and results clients have come to expect from WeissComm."
The PR firm is providing the following communications support to its new clients:
-- For BioMarin, which develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, WeissComm is conducting a disease awareness program for an enzyme replacement therapy. -- For CV Therapeutics, a biopharmaceutical company focused on novel, small molecule drugs for the treatment of cardiovascular diseases, the agency is providing product communications support for ACE inhibitor ACEON(R) (perindopril erbumine) Tablets. -- For OTN, a leading independent oncology services company, WeissComm is providing corporate and product PR support. -- For PDL, a biopharmaceutical company focused on novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer, WeissComm is providing corporate and product PR, IR and advocacy relations support.
"We hired WeissComm to provide communications support for our recently- approved enzyme replacement therapy less than a week before we received FDA approval," said Jill Jepson, product manager at BioMarin. "Within a few days, the agency provided us with a highly creative consumer-focused communications program to raise awareness of our product and the rare disease that it treats, and began planning a media initiative around the first infusion of the treatment. That media effort in a single small market led to more than one million media impressions, and the public has truly started to take notice. We are looking forward to continuing our partnership with WeissComm and its seasoned PR team with the expertise we need to achieve our key PR goals."
About WeissComm Partners
WeissComm Partners is a full-service agency focused exclusively on serving the corporate and product communications needs of leading biotechnology, pharmaceutical, device and diagnostic companies. At WeissComm, senior counselors comprise a client's everyday team. These seasoned professionals have experience both in-house and at leading global public relations agencies. They specialize in healthcare marketing, corporate and product PR, IR and advocacy relations, and have particular expertise in grassroots direct-to- patient PR programs. WeissComm serves clients through offices in San Francisco and New York and through a global alliance with U.K.-based Resolute Communications Ltd. WeissComm was recently ranked No. 54 among PR Week's agency rankings of 230 agencies nationwide.
WeissComm PartnersCONTACT: Carolyn Bumgardner Wang of WeissComm Partners, +1-415-946-1065,or Carolyn@weisscommpartners.com
